Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Incannex Healthcare Inc. (NASDAQ:IXHL – Free Report) during the fourth quarter, HoldingsChannel.com reports. The institutional investor bought 81,747 shares of the company’s stock, valued at approximately $379,000.
Incannex Healthcare Stock Performance
Shares of NASDAQ IXHL opened at $2.22 on Friday. The stock’s 50 day moving average price is $3.59 and its two-hundred day moving average price is $3.22. Incannex Healthcare Inc. has a 52-week low of $0.80 and a 52-week high of $12.68.
Incannex Healthcare (NASDAQ:IXHL – Get Free Report) last announced its quarterly earnings data on Wednesday, February 14th. The company reported ($0.33) earnings per share (EPS) for the quarter.
Incannex Healthcare Company Profile
Incannex Healthcare Inc, a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications.
See Also
- Five stocks we like better than Incannex Healthcare
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- 3 Stocks Leading the U.S. Agriculture Comeback
- 3 Healthcare Dividend Stocks to Buy
- How to Use Put Debit Spreads to Profit From Falling Stocks
- When to Sell a Stock for Profit or Loss
- Alphabet Changes the Narrative with Its First-Ever Dividend
Want to see what other hedge funds are holding IXHL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Incannex Healthcare Inc. (NASDAQ:IXHL – Free Report).
Receive News & Ratings for Incannex Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Incannex Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
